Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -132,065 | -35,513 | -27,927 | -16,941 | -88,481 |
| Depreciation Amortization | 807 | 664 | 485 | 243 | 863 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -367 |
| Accounts receivable | -4,875 | 3,699 | -27 | -75 | 186 |
| Accounts payable and accrued liabilities | -4,188 | -1,216 | -1,609 | 1,932 | -1,473 |
| Other Working Capital | 10,922 | 11,916 | -13,687 | -9,006 | 9,389 |
| Other Operating Activity | 109,324 | 9,313 | 9,628 | 3,032 | 1,558 |
| Operating Cash Flow | $-20,075 | $-11,137 | $-33,137 | $-20,815 | $-78,325 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -121 | -121 | -121 | -135 | -1,309 |
| Purchase Of Investment | -119,982 | -49,555 | -35,218 | 0 | -135,675 |
| Sale Of Investment | 86,144 | 68,630 | 51,498 | 16,968 | 183,204 |
| Purchase Sale Intangibles | -35,810 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -35,810 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-69,769 | $18,954 | $16,159 | $16,833 | $46,220 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 74,945 | 32 | N/A | N/A | 26,808 |
| Other Financing Activity | -409 | -76 | -66 | -55 | -102 |
| Financing Cash Flow | $74,536 | $-44 | $-66 | $-55 | $26,706 |
| Beginning Cash Position | 39,878 | 39,878 | 39,878 | 39,878 | 45,277 |
| End Cash Position | 24,570 | 47,651 | 22,834 | 35,841 | 39,878 |
| Net Cash Flow | $-15,308 | $7,773 | $-17,044 | $-4,037 | $-5,399 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,075 | -11,137 | -33,137 | -20,815 | -78,325 |
| Capital Expenditure | -121 | -121 | -121 | -135 | -1,309 |
| Free Cash Flow | -20,196 | -11,258 | -33,258 | -20,950 | -79,634 |